ストックスクリーナーアプリを入手
2.00
13.64%
0.24
アフターアワーズ：
2.03
0.03
+1.50%
前日終値:
$1.76
開ける：
$1.76
24時間の取引高:
2.10M
Relative Volume:
0.91
時価総額：
$81.49M
収益：
$68.68M
当期純損益:
$-60.84M
株価収益率:
-1.25
EPS:
-1.6
ネットキャッシュフロー:
$-38.42M
1週間 パフォーマンス:
+21.95%
1か月 パフォーマンス:
+23.46%
6か月 パフォーマンス:
-58.59%
1年 パフォーマンス:
-68.00%
1日の値動き範囲:
$1.74
$2.10
1週間の範囲:
$1.56
$2.89
52週間の値動き範囲:
$1.47
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
LUNG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
2.00 | 71.71M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.78B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.69B | 1.41B | 577.90M | 6.9828 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-31 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-03-10 | 開始されました | D. Boral Capital | Buy |
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-06-04 | 開始されました | Lake Street | Buy |
| 2024-02-23 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | 開始されました | Craig Hallum | Buy |
| 2023-02-27 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
| 2022-07-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-12-08 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | 開始されました | Citigroup | Buy |
| 2021-03-25 | 開始されました | Piper Sandler | Neutral |
| 2021-03-10 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-01-04 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-10-26 | 開始されました | BofA Securities | Buy |
| 2020-10-26 | 開始されました | Canaccord Genuity | Buy |
| 2020-10-26 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-10-26 | 開始されました | Stifel | Buy |
| 2020-10-26 | 開始されました | Wells Fargo | Equal Weight |
すべてを表示
Pulmonx Corp (LUNG) 最新ニュース
Is Pulmonx Corporation (LUNG) One of the Best Stocks Under $3 to Invest In? - Insider Monkey
Is Pulmonx Corporation reversing from oversold territoryWeekly Trade Report & Weekly High Potential Stock Alerts - newser.com
Historical volatility pattern of Pulmonx Corporation visualizedChart Signals & High Accuracy Swing Trade Signals - newser.com
Why Pulmonx Corporation stock remains on watchlistsJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
Is this a good reentry point in Pulmonx CorporationJuly 2025 Snapshot & Daily Profit Focused Screening - newser.com
Pulmonx (NASDAQ:LUNG) Given New $14.00 Price Target at D. Boral Capital - MarketBeat
Pulmonx (LUNG) Anticipates Q3 Revenue of $21.5 Million - GuruFocus
What hedge fund activity signals for Pulmonx Corporation stockRecession Risk & Daily Profit Maximizing Tips - newser.com
Tick level data insight on Pulmonx Corporation volatilityMarket Activity Summary & Entry Point Strategy Guides - newser.com
Lake Street Lowers Price Target for Pulmonx (LUNG) Amidst Mainta - GuruFocus
LUNG’s Surprise Revenue Surge: Key Factors - StocksToTrade
Pulmonx brings back former CEO amid leadership shakeup - Investing.com India
Pulmonx Corp (LUNG) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Pulmonx Corp (LUNG) Q3 2025 Earnings Report Preview: What To Exp - GuruFocus
Canaccord Genuity reiterates Buy rating on Pulmonx stock amid leadership changes - Investing.com Nigeria
Using data filters to optimize entry into Pulmonx CorporationQuarterly Profit Report & Fast Entry and Exit Trade Plans - newser.com
Using Python tools to backtest Pulmonx Corporation strategiesDip Buying & Fast Gain Stock Tips - newser.com
D. Boral Capital Maintains Pulmonx (LUNG) Buy Recommendation - Nasdaq
Nucor To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Analyst Lowers Price Target for Pulmonx (LUNG) While Maintaining Buy Rating | LUNG Stock News - GuruFocus
Pulmonx brings back former CEO amid leadership shakeup By Investing.com - Investing.com Australia
Will Pulmonx Corporation stock maintain momentum in 2025Weekly Gains Report & Risk Adjusted Buy/Sell Alerts - newser.com
Technical signs of recovery in Pulmonx CorporationWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
How Pulmonx Corporation stock compares to market leaders2025 Breakouts & Breakdowns & High Conviction Trade Alerts - newser.com
Healthcare Rally: Pulmonx, UHS, And X4 Lead After-Hours Gains Amid Strategic Updates - Nasdaq
What catalysts could drive Pulmonx Corporation stock higherMarket Volume Summary & Fast Exit/Entry Strategy Plans - newser.com
Visualizing Pulmonx Corporation stock with heatmaps2025 Market Outlook & Safe Capital Growth Tips - newser.com
Pulmonx Corp (LUNG) Q3 2025 Earnings: Revenue Surpasses Estimates at $21.5 Million - GuruFocus
LUNG to Discuss Q3 2025 Results and Annual Outlook in November C - GuruFocus
Pulmonx Announces Leadership Changes with New CEO - TipRanks
Pulmonx announces management transition and preliminary third quarter 2025 revenue reschedules third quarter 2025 earnings call to November 12, 2025 - MarketScreener
Pulmonx Announces Management Transition And Preliminary Third Quarter 2025 Revenue Reschedules Third Quarter 2025 Earnings Call To November 12, 2025 - TradingView
Pulmonx Corporation Announces Leadership Transition and Preliminary Third Quarter 2025 Revenue Estimates - Quiver Quantitative
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025 - The Manila Times
Pulmonx Corporation Announces CEO Changes, Effective October 27, 2025 - MarketScreener
Pulmonx (Nasdaq: LUNG) reappoints Glen French as CEO; preliminary Q3 revenue ~$21.5M - Stock Titan
Real time social sentiment graph for Pulmonx CorporationPortfolio Growth Summary & High Conviction Buy Zone Picks - newser.com
Can Pulmonx Corporation stock withstand economic slowdownTrade Analysis Report & AI Powered Buy/Sell Recommendations - newser.com
Pulmonx Corp (LUNG) 財務データ
収益
当期純利益
現金流量
EPS
0.34%
14.63%
大文字化:
|
ボリューム (24 時間):